LOTUSEYE: Lotus Eye Hospital and Institute Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Lotus Eye Hospital and Institute Limited has submitted a compliance certificate under SEBI Regulation 74(5) for Q4 FY2026 (ending March 31, 2026). The filing confirms that securities received for dematerialization were properly processed by their Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The certificate states that dematerialized security certificates were mutilated and cancelled after verification, and depositories were substituted as registered owners within the prescribed 15-day timeline. The company also confirms that all dematerialized securities remain listed on BSE and NSE where the original securities were listed. This is a routine quarterly regulatory compliance filing.
No impact on shareholders or stock price. This is a standard procedural filing confirming proper handling of dematerialization requests by the company's registrar, as required by SEBI regulations. No material corporate action is indicated.